Global Upstream Bioprocessing Market Projected to Reach $25 Billion by 2030 - Analysis by Product Type, Workflow, Usage Type, Mode, and Region [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Regional Share, Trends, and Growth Opportunity Analysis" report has been added to ResearchAndMarkets.com's offering. The global upstream bioprocessing market is on a steep trajectory of growth, with projections to reach a valuation of US$ 25.046 billion by 2030. This market, which stood at US$ 9.174 billion in 2022, is expected to flourish at a CAGR of 13.4% between 2022 and 2030. The adoption of single-use bioreactors, growth of the biopharmaceutical sector, and robust outsourcing trends in bio-manufacturing drive the upstream bioprocessing market forward. With a focus on developments like the integration of Repligen Corporation's XCell ATF technology with Sartorius Biostat STR in September 2023, the market has been introduced to technological innovations enhancing process efficiency and adaptability. Recent Technological Advancements in Upstream Bioprocessing Innovative technological advancements in the sector, such as advanced cell culture systems and bioreactor designs, ar
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Should be Confident in Repligen Corporation (RGEN)'s Long-Term Growth Potential? [Yahoo! Finance]Yahoo! Finance
- Danaher gains as Q1 results exceed expectations [Seeking Alpha]Seeking Alpha
- Repligen to Report First Quarter 2024 Financial ResultsGlobeNewswire
- Repligen Appoints Maggie A. Pax to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Repligen Appoints Maggie A. Pax to Board of DirectorsGlobeNewswire
RGEN
Earnings
- 2/21/24 - In-Line
RGEN
Sec Filings
- 4/4/24 - Form 4
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- RGEN's page on the SEC website